0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasmid Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-24Q5634
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Plasmid Market Insights and Forecast to 2028

Global Plasmid Market Insights and Forecast to 2028

Code: QYRE-Auto-24Q5634
Report
May 2022
119 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Plasmid Market

The global Plasmid market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, F-Plasmids accounting for % of the Plasmid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Transfection segment is altered to an % CAGR throughout this forecast period.
China Plasmid market size is valued at US$ million in 2021, while the North America and Europe Plasmid are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Plasmid landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasmid market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasmid market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasmid market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasmid market.
Global Plasmid Scope and Market Size
Plasmid market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Plasmid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids

Segment by Application

Transfection
Recombinant DNA Technology
Gene Therapy
Others

BY COMPANY

Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
GenePharma
Polyplus Transfection

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 F-Plasmids
1.2.3 Col Plasmids
1.2.4 Resistance Plasmids
1.2.5 Cryptic Plasmids
1.2.6 Degradative Plasmids
1.2.7 Virulence Plasmids
1.3 Market by Application
1.3.1 Global Plasmid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Market Perspective (2017-2028)
2.2 Plasmid Growth Trends by Region
2.2.1 Plasmid Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmid Historic Market Size by Region (2017-2022)
2.2.3 Plasmid Forecasted Market Size by Region (2023-2028)
2.3 Plasmid Market Dynamics
2.3.1 Plasmid Industry Trends
2.3.2 Plasmid Market Drivers
2.3.3 Plasmid Market Challenges
2.3.4 Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Players by Revenue
3.1.1 Global Top Plasmid Players by Revenue (2017-2022)
3.1.2 Global Plasmid Revenue Market Share by Players (2017-2022)
3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid Revenue
3.4 Global Plasmid Market Concentration Ratio
3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2021
3.5 Plasmid Key Players Head office and Area Served
3.6 Key Players Plasmid Product Solution and Service
3.7 Date of Enter into Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Breakdown Data by Type
4.1 Global Plasmid Historic Market Size by Type (2017-2022)
4.2 Global Plasmid Forecasted Market Size by Type (2023-2028)
5 Plasmid Breakdown Data by Application
5.1 Global Plasmid Historic Market Size by Application (2017-2022)
5.2 Global Plasmid Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmid Market Size (2017-2028)
6.2 North America Plasmid Market Size by Type
6.2.1 North America Plasmid Market Size by Type (2017-2022)
6.2.2 North America Plasmid Market Size by Type (2023-2028)
6.2.3 North America Plasmid Market Share by Type (2017-2028)
6.3 North America Plasmid Market Size by Application
6.3.1 North America Plasmid Market Size by Application (2017-2022)
6.3.2 North America Plasmid Market Size by Application (2023-2028)
6.3.3 North America Plasmid Market Share by Application (2017-2028)
6.4 North America Plasmid Market Size by Country
6.4.1 North America Plasmid Market Size by Country (2017-2022)
6.4.2 North America Plasmid Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Plasmid Market Size (2017-2028)
7.2 Europe Plasmid Market Size by Type
7.2.1 Europe Plasmid Market Size by Type (2017-2022)
7.2.2 Europe Plasmid Market Size by Type (2023-2028)
7.2.3 Europe Plasmid Market Share by Type (2017-2028)
7.3 Europe Plasmid Market Size by Application
7.3.1 Europe Plasmid Market Size by Application (2017-2022)
7.3.2 Europe Plasmid Market Size by Application (2023-2028)
7.3.3 Europe Plasmid Market Share by Application (2017-2028)
7.4 Europe Plasmid Market Size by Country
7.4.1 Europe Plasmid Market Size by Country (2017-2022)
7.4.2 Europe Plasmid Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Market Size (2017-2028)
8.2 Asia-Pacific Plasmid Market Size by Type
8.2.1 Asia-Pacific Plasmid Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmid Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmid Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmid Market Size by Application
8.3.1 Asia-Pacific Plasmid Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmid Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmid Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmid Market Size by Region
8.4.1 Asia-Pacific Plasmid Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmid Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid Market Size (2017-2028)
9.2 Latin America Plasmid Market Size by Type
9.2.1 Latin America Plasmid Market Size by Type (2017-2022)
9.2.2 Latin America Plasmid Market Size by Type (2023-2028)
9.2.3 Latin America Plasmid Market Share by Type (2017-2028)
9.3 Latin America Plasmid Market Size by Application
9.3.1 Latin America Plasmid Market Size by Application (2017-2022)
9.3.2 Latin America Plasmid Market Size by Application (2023-2028)
9.3.3 Latin America Plasmid Market Share by Application (2017-2028)
9.4 Latin America Plasmid Market Size by Country
9.4.1 Latin America Plasmid Market Size by Country (2017-2022)
9.4.2 Latin America Plasmid Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Market Size (2017-2028)
10.2 Middle East & Africa Plasmid Market Size by Type
10.2.1 Middle East & Africa Plasmid Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmid Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmid Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmid Market Size by Application
10.3.1 Middle East & Africa Plasmid Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmid Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmid Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmid Market Size by Country
10.4.1 Middle East & Africa Plasmid Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmid Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aldevron
11.1.1 Aldevron Company Details
11.1.2 Aldevron Business Overview
11.1.3 Aldevron Plasmid Introduction
11.1.4 Aldevron Revenue in Plasmid Business (2017-2022)
11.1.5 Aldevron Recent Developments
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Plasmid Introduction
11.2.4 GenScript Revenue in Plasmid Business (2017-2022)
11.2.5 GenScript Recent Developments
11.3 PlasmidFactory GmbH & Co. KG
11.3.1 PlasmidFactory GmbH & Co. KG Company Details
11.3.2 PlasmidFactory GmbH & Co. KG Business Overview
11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction
11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2017-2022)
11.3.5 PlasmidFactory GmbH & Co. KG Recent Developments
11.4 VGXI Inc.
11.4.1 VGXI Inc. Company Details
11.4.2 VGXI Inc. Business Overview
11.4.3 VGXI Inc. Plasmid Introduction
11.4.4 VGXI Inc. Revenue in Plasmid Business (2017-2022)
11.4.5 VGXI Inc. Recent Developments
11.5 Oxford Genetics Ltd.
11.5.1 Oxford Genetics Ltd. Company Details
11.5.2 Oxford Genetics Ltd. Business Overview
11.5.3 Oxford Genetics Ltd. Plasmid Introduction
11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2017-2022)
11.5.5 Oxford Genetics Ltd. Recent Developments
11.6 Applied StemCell
11.6.1 Applied StemCell Company Details
11.6.2 Applied StemCell Business Overview
11.6.3 Applied StemCell Plasmid Introduction
11.6.4 Applied StemCell Revenue in Plasmid Business (2017-2022)
11.6.5 Applied StemCell Recent Developments
11.7 Altogen Biosystems
11.7.1 Altogen Biosystems Company Details
11.7.2 Altogen Biosystems Business Overview
11.7.3 Altogen Biosystems Plasmid Introduction
11.7.4 Altogen Biosystems Revenue in Plasmid Business (2017-2022)
11.7.5 Altogen Biosystems Recent Developments
11.8 Cobra Biologics
11.8.1 Cobra Biologics Company Details
11.8.2 Cobra Biologics Business Overview
11.8.3 Cobra Biologics Plasmid Introduction
11.8.4 Cobra Biologics Revenue in Plasmid Business (2017-2022)
11.8.5 Cobra Biologics Recent Developments
11.9 Copernicus Therapeutics Inc.
11.9.1 Copernicus Therapeutics Inc. Company Details
11.9.2 Copernicus Therapeutics Inc. Business Overview
11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction
11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2017-2022)
11.9.5 Copernicus Therapeutics Inc. Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Plasmid Introduction
11.10.4 Takara Bio Revenue in Plasmid Business (2017-2022)
11.10.5 Takara Bio Recent Developments
11.11 InvivoGen
11.11.1 InvivoGen Company Details
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen Plasmid Introduction
11.11.4 InvivoGen Revenue in Plasmid Business (2017-2022)
11.11.5 InvivoGen Recent Developments
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Details
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Plasmid Introduction
11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2017-2022)
11.12.5 Miltenyi Biotec Recent Developments
11.13 Medigene Sdn Bhd
11.13.1 Medigene Sdn Bhd Company Details
11.13.2 Medigene Sdn Bhd Business Overview
11.13.3 Medigene Sdn Bhd Plasmid Introduction
11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2017-2022)
11.13.5 Medigene Sdn Bhd Recent Developments
11.14 MaxCyte Inc.
11.14.1 MaxCyte Inc. Company Details
11.14.2 MaxCyte Inc. Business Overview
11.14.3 MaxCyte Inc. Plasmid Introduction
11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2017-2022)
11.14.5 MaxCyte Inc. Recent Developments
11.15 Mirus Bio LLC
11.15.1 Mirus Bio LLC Company Details
11.15.2 Mirus Bio LLC Business Overview
11.15.3 Mirus Bio LLC Plasmid Introduction
11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2017-2022)
11.15.5 Mirus Bio LLC Recent Developments
11.16 MolMed S.p.A.
11.16.1 MolMed S.p.A. Company Details
11.16.2 MolMed S.p.A. Business Overview
11.16.3 MolMed S.p.A. Plasmid Introduction
11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2017-2022)
11.16.5 MolMed S.p.A. Recent Developments
11.17 GenePharma
11.17.1 GenePharma Company Details
11.17.2 GenePharma Business Overview
11.17.3 GenePharma Plasmid Introduction
11.17.4 GenePharma Revenue in Plasmid Business (2017-2022)
11.17.5 GenePharma Recent Developments
11.18 Polyplus Transfection
11.18.1 Polyplus Transfection Company Details
11.18.2 Polyplus Transfection Business Overview
11.18.3 Polyplus Transfection Plasmid Introduction
11.18.4 Polyplus Transfection Revenue in Plasmid Business (2017-2022)
11.18.5 Polyplus Transfection Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Plasmid Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of F-Plasmids
    Table 3. Key Players of Col Plasmids
    Table 4. Key Players of Resistance Plasmids
    Table 5. Key Players of Cryptic Plasmids
    Table 6. Key Players of Degradative Plasmids
    Table 7. Key Players of Virulence Plasmids
    Table 8. Global Plasmid Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Plasmid Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Plasmid Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Plasmid Market Share by Region (2017-2022)
    Table 12. Global Plasmid Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Plasmid Market Share by Region (2023-2028)
    Table 14. Plasmid Market Trends
    Table 15. Plasmid Market Drivers
    Table 16. Plasmid Market Challenges
    Table 17. Plasmid Market Restraints
    Table 18. Global Plasmid Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Plasmid Revenue Share by Players (2017-2022)
    Table 20. Global Top Plasmid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2021)
    Table 21. Ranking of Global Top Plasmid Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Plasmid Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Plasmid Product Solution and Service
    Table 25. Date of Enter into Plasmid Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Plasmid Revenue Market Share by Type (2017-2022)
    Table 29. Global Plasmid Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Plasmid Revenue Market Share by Type (2023-2028)
    Table 31. Global Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Plasmid Revenue Share by Application (2017-2022)
    Table 33. Global Plasmid Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Plasmid Revenue Share by Application (2023-2028)
    Table 35. North America Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Plasmid Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Plasmid Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Plasmid Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Plasmid Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Plasmid Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Plasmid Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Plasmid Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Plasmid Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Plasmid Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Plasmid Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Plasmid Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Plasmid Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Plasmid Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Plasmid Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Plasmid Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Plasmid Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Plasmid Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Plasmid Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Plasmid Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Plasmid Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Plasmid Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Plasmid Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Aldevron Company Details
    Table 66. Aldevron Business Overview
    Table 67. Aldevron Plasmid Product
    Table 68. Aldevron Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 69. Aldevron Recent Developments
    Table 70. GenScript Company Details
    Table 71. GenScript Business Overview
    Table 72. GenScript Plasmid Product
    Table 73. GenScript Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 74. GenScript Recent Developments
    Table 75. PlasmidFactory GmbH & Co. KG Company Details
    Table 76. PlasmidFactory GmbH & Co. KG Business Overview
    Table 77. PlasmidFactory GmbH & Co. KG Plasmid Product
    Table 78. PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 79. PlasmidFactory GmbH & Co. KG Recent Developments
    Table 80. VGXI Inc. Company Details
    Table 81. VGXI Inc. Business Overview
    Table 82. VGXI Inc. Plasmid Product
    Table 83. VGXI Inc. Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 84. VGXI Inc. Recent Developments
    Table 85. Oxford Genetics Ltd. Company Details
    Table 86. Oxford Genetics Ltd. Business Overview
    Table 87. Oxford Genetics Ltd. Plasmid Product
    Table 88. Oxford Genetics Ltd. Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 89. Oxford Genetics Ltd. Recent Developments
    Table 90. Applied StemCell Company Details
    Table 91. Applied StemCell Business Overview
    Table 92. Applied StemCell Plasmid Product
    Table 93. Applied StemCell Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 94. Applied StemCell Recent Developments
    Table 95. Altogen Biosystems Company Details
    Table 96. Altogen Biosystems Business Overview
    Table 97. Altogen Biosystems Plasmid Product
    Table 98. Altogen Biosystems Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 99. Altogen Biosystems Recent Developments
    Table 100. Cobra Biologics Company Details
    Table 101. Cobra Biologics Business Overview
    Table 102. Cobra Biologics Plasmid Product
    Table 103. Cobra Biologics Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 104. Cobra Biologics Recent Developments
    Table 105. Copernicus Therapeutics Inc. Company Details
    Table 106. Copernicus Therapeutics Inc. Business Overview
    Table 107. Copernicus Therapeutics Inc. Plasmid Product
    Table 108. Copernicus Therapeutics Inc. Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 109. Copernicus Therapeutics Inc. Recent Developments
    Table 110. Takara Bio Company Details
    Table 111. Takara Bio Business Overview
    Table 112. Takara Bio Plasmid Product
    Table 113. Takara Bio Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 114. Takara Bio Recent Developments
    Table 115. InvivoGen Company Details
    Table 116. InvivoGen Business Overview
    Table 117. InvivoGen Plasmid Product
    Table 118. InvivoGen Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 119. InvivoGen Recent Developments
    Table 120. Miltenyi Biotec Company Details
    Table 121. Miltenyi Biotec Business Overview
    Table 122. Miltenyi Biotec Plasmid Product
    Table 123. Miltenyi Biotec Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 124. Miltenyi Biotec Recent Developments
    Table 125. Medigene Sdn Bhd Company Details
    Table 126. Medigene Sdn Bhd Business Overview
    Table 127. Medigene Sdn Bhd Plasmid Product
    Table 128. Medigene Sdn Bhd Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 129. Medigene Sdn Bhd Recent Developments
    Table 130. MaxCyte Inc. Company Details
    Table 131. MaxCyte Inc. Business Overview
    Table 132. MaxCyte Inc. Plasmid Product
    Table 133. MaxCyte Inc. Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 134. MaxCyte Inc. Recent Developments
    Table 135. Mirus Bio LLC Company Details
    Table 136. Mirus Bio LLC Business Overview
    Table 137. Mirus Bio LLC Plasmid Product
    Table 138. Mirus Bio LLC Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 139. Mirus Bio LLC Recent Developments
    Table 140. MolMed S.p.A. Company Details
    Table 141. MolMed S.p.A. Business Overview
    Table 142. MolMed S.p.A. Plasmid Product
    Table 143. MolMed S.p.A. Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 144. MolMed S.p.A. Recent Developments
    Table 145. GenePharma Company Details
    Table 146. GenePharma Business Overview
    Table 147. GenePharma Plasmid Product
    Table 148. GenePharma Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 149. GenePharma Recent Developments
    Table 150. Polyplus Transfection Company Details
    Table 151. Polyplus Transfection Business Overview
    Table 152. Polyplus Transfection Plasmid Product
    Table 153. Polyplus Transfection Revenue in Plasmid Business (2017-2022) & (US$ Million)
    Table 154. Polyplus Transfection Recent Developments
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plasmid Market Share by Type: 2021 VS 2028
    Figure 2. F-Plasmids Features
    Figure 3. Col Plasmids Features
    Figure 4. Resistance Plasmids Features
    Figure 5. Cryptic Plasmids Features
    Figure 6. Degradative Plasmids Features
    Figure 7. Virulence Plasmids Features
    Figure 8. Global Plasmid Market Share by Application: 2021 VS 2028
    Figure 9. Transfection Case Studies
    Figure 10. Recombinant DNA Technology Case Studies
    Figure 11. Gene Therapy Case Studies
    Figure 12. Others Case Studies
    Figure 13. Plasmid Report Years Considered
    Figure 14. Global Plasmid Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Plasmid Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Plasmid Market Share by Region: 2021 VS 2028
    Figure 17. Global Plasmid Market Share by Players in 2021
    Figure 18. Global Top Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Plasmid Revenue in 2021
    Figure 20. North America Plasmid Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Plasmid Market Size Market Share by Type (2017-2028)
    Figure 22. North America Plasmid Market Size Market Share by Application (2017-2028)
    Figure 23. North America Plasmid Market Size Share by Country (2017-2028)
    Figure 24. United States Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Plasmid Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Plasmid Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Plasmid Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Plasmid Market Size Share by Country (2017-2028)
    Figure 30. Germany Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Plasmid Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Plasmid Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Plasmid Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Plasmid Market Size Share by Region (2017-2028)
    Figure 40. China Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Plasmid Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Plasmid Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Plasmid Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Plasmid Market Size Share by Country (2017-2028)
    Figure 50. Mexico Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Plasmid Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Plasmid Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Plasmid Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Plasmid Market Size Share by Country (2017-2028)
    Figure 56. Turkey Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Aldevron Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 60. GenScript Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 61. PlasmidFactory GmbH & Co. KG Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 62. VGXI Inc. Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 63. Oxford Genetics Ltd. Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 64. Applied StemCell Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 65. Altogen Biosystems Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 66. Cobra Biologics Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 67. Copernicus Therapeutics Inc. Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 68. Takara Bio Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 69. InvivoGen Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 70. Miltenyi Biotec Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 71. Medigene Sdn Bhd Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 72. MaxCyte Inc. Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 73. Mirus Bio LLC Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 74. MolMed S.p.A. Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 75. GenePharma Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 76. Polyplus Transfection Revenue Growth Rate in Plasmid Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart